Prooxidative-Antioxidative Balance of Cells in Different Types of Renal Replacement Therapy

Abstract

Background: Patients suffering from chronic kidney disease (CKD) are exposed to increased oxidative stress and disturbances manifesting in the enzymatic and non-enzymatic antioxidative defence system. The object of the research was to assess the differences between conservative treatment, peritoneal dialysis and haemodialysis in moderating cellular antioxidative agents. Methods: The group examined comprised 145 patients. The activities of superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase were obtained using kinetic methods. The spectrophotometric method established the concentrations of reduced glutathione, albumin, uric acid, glucose, total protein and lipids. Results: The type of treatment determined significant changes in antioxidative enzyme activities and concentrations of non-enzymatic antioxidative compounds. Conclusions: Peritoneal dialysis provides better antioxidant protection than other types of therapy in CKD and should be considered as first-choice treatment despite more metabolic disorders.

Effect of acute intradialytic strength physical exercise on oxidative stress and inflammatory responses in hemodialysis patients

“…Interestingly, our results showed an increase in plasma SOD levels 1 hour after initiating the dialysis session. Varan et al [5] and Stępniewska et al [28] found the same results at the end of the dialysis session. This increase may be explained by a compensatory mechanism that mobilizes the antioxidant defense system and prevents the free radicals produced during the dialysis session.…”

Serum Glutaredoxin Activity as a Marker of Oxidative Stress in Chronic Kidney Disease: A Pilot Study

“…Importantly, CKD affects red blood cell and platelets that are activated and produce reactive oxygen species, which in turn activates intracellular redox enzymes, for example, superoxide dismutase, catalase, glutathione peroxidase, transferases, and glutathione reductase [6], showing and increased redox imbalance in platelets and red blood cells of CKD patients [5,6,[18][19][20][21]. Markers of protein and lipid peroxidation, for example, malondialdehyde (MDA/TBARS), advanced glycation end products including pentosidine [7,8], advanced oxidation protein products [1,5] are also altered in CKD; however, to date, there are no redox markers that are readily used in the point-of-care testing.…”

Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients

“…Iron therapy, especially intravenous iron, has been found to increase free ion and induce the peroxidation of lipid and protein, aggravate the microinflammation, and result in increased SOD and CRP ( 17 – 20 ). SOD, as an antioxidant enzyme representative, can remove oxygen-free radicals and block the damage caused by free radicals, thereby reflecting the level of oxidative stress ( 18 – 20 ).…”